novel
coronaviru
declar
new
intern
health
emerg
specif
drug
yet
identifi
sever
method
current
evalu
proteas
glycosyl
spike
protein
inhibitor
outlin
main
fusion
site
among
coronaviru
host
cell
notwithstand
heptad
repeat
domain
glycosyl
spike
protein
region
less
mutabl
encourag
target
new
inhibitor
drug
novelti
propos
approach
compar
other
lie
precis
train
deep
neural
network
toward
viru
siames
neural
network
snn
train
distingu
whole
protein
sequenc
amongst
two
differ
virus
famili
ebola
way
present
deep
learn
system
precis
knowledg
peptid
linkag
among
protein
structur
differ
work
trivial
train
public
dataset
provid
ligandpeptid
inform
suddenli
snn
show
sensit
peptid
affin
classif
peptid
satpdb
bank
test
toward
specif
region
exhibit
affin
peptidylprolyl
cistran
isomeras
ppias
peptid
affin
ppias
open
new
horizon
research
sinc
sever
scientif
paper
alreadi
shown
csa
immunosuppress
drug
main
inhibitor
ppias
suppress
reproduct
differ
cov
viru
includ
sarscov
merscov
final
ensur
scientif
reproduc
code
data
made
public
follow
link
http
risen
citi
wuhan
china
hube
extraordinari
infect
human
pathogen
produc
critic
respiratori
ill
pneumonia
decemb
three
bronchoalveolar
lavag
sampl
obtain
patient
pneumonia
unfamiliar
etiolog
complet
viru
genom
sequenc
acquir
indic
relationship
bat
sarslik
coronaviru
present
numer
coronaviru
sequenc
publish
genbank
allow
direct
studi
viru
structur
high
mutat
recombin
rate
viru
make
difficult
design
wide
spectrum
inhibitor
convent
target
sever
approach
evalu
first
approach
viru
proteas
inhibit
prevent
viru
polypeptid
filament
split
therefor
viral
core
protein
built
instanc
nelfinavir
proteas
inhibitor
treat
hiv
prophesi
like
inhibitor
princip
proteas
differ
molecular
dock
computationalbas
second
strategi
target
glycosyl
spike
protein
fusion
entri
host
cell
repres
promis
target
develop
new
inhibitor
target
site
spike
notwithstand
unclear
whether
also
hold
similar
fusion
entri
mechan
sarscov
merscov
true
consequ
site
also
serv
import
target
develop
fusionentri
inhibitor
though
also
unexplor
also
exist
compar
fusion
entri
mechan
sarscov
merscov
despit
deep
learn
method
sharpen
engend
new
molecul
yet
clinic
test
convers
comput
drug
repurpos
give
effici
fast
approach
test
drug
alreadi
avail
among
repurpos
comput
approach
four
molecul
previous
select
main
candid
prulifloxacin
bictegravir
nelfinavir
tegobuvi
prulifloxacin
synthet
antibiot
fluoroquinolon
class
bictegravir
antiretrovir
block
enzym
integras
use
capabl
insert
viral
genom
host
one
nelfinavir
proteas
inhibitor
well
use
treatment
tegobuvi
nonnucleosid
revers
transcriptas
inhibitor
nnrti
exhibit
antivir
activ
patient
genotyp
chronic
hcv
infect
howev
none
molecul
specif
inhibit
target
glycosyl
spike
protein
specif
protein
spike
made
two
subunit
subunit
bind
cell
receptor
receptorbind
domain
rbd
follow
set
conform
chang
subunit
allow
fusion
peptid
enter
cell
membran
host
cell
region
find
anoth
region
call
heptad
repeat
three
hydrophob
groov
bind
high
region
call
heptad
repeat
form
structur
six
helic
help
bring
two
membran
closer
togeth
final
fusion
henc
entranc
rbd
cov
famili
highli
mutabl
region
suitabl
inhibit
hr
region
subunit
conserv
among
variou
hcov
recent
sever
deep
learn
algorithm
employ
research
coronaviru
target
drug
exampl
threedimension
model
viru
sequenc
translat
protein
within
classif
network
among
ligand
protein
input
interact
screen
gener
adversari
approach
also
use
produc
novel
target
molecular
structur
howev
two
main
limit
approach
mostli
supervis
train
approach
public
dataset
specif
ground
truth
ligand
ii
base
shallow
nonconvolut
network
current
state
art
mani
dataset
iii
gener
new
molecul
yet
test
clinic
reason
purpos
paper
introduc
new
artifici
intellig
model
speed
research
promis
target
ligand
base
complex
comput
expens
molecular
dock
oper
ii
fast
screen
main
antibacteri
anticanc
antimicrobi
peptid
present
satpdb
toward
domain
alreadi
mention
describ
limit
mutat
spike
protein
site
ii
moreov
introduc
new
deep
learn
method
base
trivial
supervis
classif
ligand
peptid
public
dataset
oneshot
learn
approach
specif
studi
glycosyl
spike
protein
workflow
subdivid
three
stage
viru
genom
convers
protein
subsequ
split
protein
sequenc
within
peptid
filament
text
filament
peptid
imag
convers
final
peptid
comparison
siames
neural
network
snn
avail
genom
genbank
sequenc
use
sequenc
obtain
man
hospit
central
hospit
wuhan
decemb
viral
genom
structur
determin
align
sequenc
two
characterist
portion
betacoronaviru
famili
coronaviru
link
human
sarscov
genbank
access
number
coronaviru
correl
bat
bat
genbank
access
number
genom
sequenc
convert
toward
correspond
protein
sequenc
ten
protein
extract
seri
form
protein
peptid
fig
subsequ
proteinpeptid
convert
imag
pixel
fig
method
similar
deepvari
work
genom
sequenc
transform
rgb
pixel
imag
directli
process
stateofart
convolut
neural
network
cnn
genotyp
predict
enabl
handl
singl
text
string
imag
use
advantag
cnn
current
repres
state
art
multipl
task
sever
dataset
particular
smallest
variat
protein
sequenc
effici
recogn
multipl
nonlinear
layer
neural
network
snn
train
identifi
whole
protein
structur
versu
two
distinct
famili
virus
ebola
equival
genometoprotein
translat
done
though
oneshot
learn
system
reduc
use
specif
dataset
enabl
directli
work
avail
biolog
data
word
network
learn
discrimin
target
exampl
protein
domain
domain
complet
differ
biolog
characterist
without
explicit
use
specif
dataset
appli
deep
snn
lean
gener
imag
function
make
infer
unknown
distribut
ii
provid
valid
approach
explor
solut
unknown
domain
without
reli
trivial
supervis
train
dataset
ie
peptid
ligand
correspond
iii
use
sever
statesoftheart
cnn
previous
pretrain
huge
dataset
model
design
two
cnn
take
distinct
imag
input
fig
input
first
network
alway
sequenc
peptid
second
accept
either
peptid
sequenc
randomli
choos
differ
viru
famili
ebola
sequenc
ie
first
network
therefor
two
input
equival
ie
equal
protein
sequenc
ground
truth
target
util
train
model
one
otherwis
zero
even
though
two
distinct
type
cnn
use
shallow
deep
version
notabl
shallow
variant
alexnet
employ
especi
pretrain
version
alexnet
million
imag
imagenet
databas
also
appli
deep
version
use
resnext
fifti
layer
deep
notabl
final
convolut
layer
cnn
flatten
vector
pair
pass
final
layer
calcul
metric
within
sigmoid
output
function
model
train
stochast
gradient
descent
sdg
nesterov
acceler
gradient
nag
learn
rate
epoch
loss
function
mean
squar
error
mse
random
resiz
crop
random
horizont
flip
random
vertic
flip
made
prevent
overfit
train
phase
train
model
dataset
imag
gener
correspond
posit
proteic
exampl
neg
one
ebola
dataset
subsequ
divid
train
valid
test
respect
model
capac
distinguish
protein
sequenc
viral
famili
estim
within
sensit
analysi
eq
p
true
posit
ie
sequenc
correctli
identifi
sequenc
f
n
fals
neg
ie
sequenc
incorrectli
identifi
ebola
fig
valid
plot
train
phase
see
alexnet
pretrain
imagenet
show
better
abil
better
learn
earliest
epoch
compar
preperin
version
instead
deep
network
resnext
show
limit
abil
adapt
learn
probabl
due
small
dataset
avail
previous
mention
two
differ
cnn
appli
ie
alexnet
resnext
get
best
perform
valid
test
data
set
importantli
small
eight
layer
alexnet
shown
perform
sever
tini
clinic
dataset
confirm
best
network
compar
deeper
version
resnext
also
pretrain
imagenet
made
fifti
layer
inde
point
valid
plot
fig
pretrain
alexnet
show
reliabl
converg
correl
pretrain
one
toward
resnext
probabl
due
presenc
small
dataset
perform
larg
deep
network
instead
show
slow
converg
ie
blu
line
fig
sensit
analysi
test
set
confirm
observ
valid
phase
wherea
pretrain
alexnet
version
promin
sensit
compar
pretrain
version
resnext
deep
network
select
phase
alexnet
pretrain
model
chosen
make
infer
peptid
satpdb
find
closest
peptid
target
domain
site
infer
process
perform
follow
sequenc
cut
eight
subpeptid
ten
protein
fig
convert
imag
fig
pixel
ii
separ
satpdb
peptid
convert
text
imag
pixel
fig
iii
everi
singl
peptid
given
input
first
siames
cnn
network
eight
subpeptid
paid
second
siames
cnn
sequenti
iv
final
final
siames
sigmoid
output
target
satpdb
peptid
eight
subpeptid
averag
infer
process
show
affin
ikkt
eeikkt
eeikkt
eeikkt
eeierdw
em
v
peptidylprolyl
cistran
isomeras
peptid
domain
articl
novel
drug
repurpos
approach
explor
snn
design
find
best
match
peptid
insid
region
repres
less
mutabl
domain
coronaviru
propos
model
achiev
reason
perform
overal
sensit
test
set
within
two
comparison
model
particularli
shallow
pretrain
version
alexnet
appli
show
better
perform
deep
version
one
resnext
tab
protein
sequenc
dataset
imag
extract
ebola
train
snn
classifi
protein
sequenc
similar
compar
belong
differ
virus
famili
ie
ebola
wherea
lack
train
set
size
justifi
greater
abil
shallow
network
perform
better
compar
deep
one
ie
resnet
howev
oneshot
learn
approach
appli
suitabl
supervis
ligandprotein
classif
need
larg
train
dataset
learn
correct
ligand
ii
neural
network
focus
learn
interest
protein
sequenc
iii
public
dataset
train
exampl
ligand
bind
specif
carnivor
ie
creat
incorrect
classif
infer
peptid
satpdb
taken
show
confid
peptidylprolyl
cistran
isomeras
affin
domain
peptidylprolyl
cistran
isomeras
known
peptidylprolyl
isomeras
ppias
enzym
fig
transform
ci
tran
isom
amino
acid
prolin
two
major
famili
ppias
cyp
protein
fkbp
cyp
implic
broad
spectrum
cellular
process
includ
cell
signal
protein
fold
protein
traffick
affin
ppias
may
play
essenti
role
identif
ppias
inhibitor
sever
therapi
csa
immunosuppress
drug
sever
scientif
paper
note
cellular
cultur
reproduct
differ
cov
includ
sarscov
merscov
inhibit
csa
therapi
well
recogn
csa
immunosuppress
drug
sirolimu
ppias
inhibitor
shown
enhanc
result
patient
intract
pneumonia
recent
comput
studi
show
sirolimu
also
select
potenti
drug
confirm
observ
work
ppias
affin
order
provid
reproduc
work
code
data
made
avail
scientif
commun
http
futur
work
thu
still
need
confirm
associ
mechan
ppias
molecular
dock
studi
therefor
import
understand
biolog
mechan
ppias
